250 related articles for article (PubMed ID: 26115074)
21. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal-epithelial transitions: spontaneous and cumulative syntheses of epithelial marker molecules and their assemblies to novel cell junctions connecting human hematopoietic tumor cells to carcinomatoid tissue structures.
Franke WW; Rickelt S
Int J Cancer; 2011 Dec; 129(11):2588-99. PubMed ID: 21647878
[TBL] [Abstract][Full Text] [Related]
23. The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery.
Cirillo N; Lanza M; De Rosa A; Cammarota M; La Gatta A; Gombos F; Lanza A
J Cell Biochem; 2008 Feb; 103(2):598-606. PubMed ID: 17559062
[TBL] [Abstract][Full Text] [Related]
24. Moxibustion combined with acupuncture increases tight junction protein expression in Crohn's disease patients.
Shang HX; Wang AQ; Bao CH; Wu HG; Chen WF; Wu LY; Ji R; Zhao JM; Shi Y
World J Gastroenterol; 2015 Apr; 21(16):4986-96. PubMed ID: 25945013
[TBL] [Abstract][Full Text] [Related]
25. Krüppel-like factor 5 is essential for maintenance of barrier function in mouse colon.
Liu Y; Chidgey M; Yang VW; Bialkowska AB
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G478-G491. PubMed ID: 28864500
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
Zeissig S; Bojarski C; Buergel N; Mankertz J; Zeitz M; Fromm M; Schulzke JD
Gut; 2004 Sep; 53(9):1295-302. PubMed ID: 15306588
[TBL] [Abstract][Full Text] [Related]
27. Desmosomal cadherins utilize distinct kinesins for assembly into desmosomes.
Nekrasova OE; Amargo EV; Smith WO; Chen J; Kreitzer GE; Green KJ
J Cell Biol; 2011 Dec; 195(7):1185-203. PubMed ID: 22184201
[TBL] [Abstract][Full Text] [Related]
28. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells.
Hütz K; Zeiler J; Sachs L; Ormanns S; Spindler V
Mol Carcinog; 2017 Aug; 56(8):1884-1895. PubMed ID: 28277619
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal unique region of desmoglein 2 inhibits its internalization via tail-tail interactions.
Chen J; Nekrasova OE; Patel DM; Klessner JL; Godsel LM; Koetsier JL; Amargo EV; Desai BV; Green KJ
J Cell Biol; 2012 Nov; 199(4):699-711. PubMed ID: 23128240
[TBL] [Abstract][Full Text] [Related]
30. Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins.
Schäfer S; Koch PJ; Franke WW
Exp Cell Res; 1994 Apr; 211(2):391-9. PubMed ID: 8143788
[TBL] [Abstract][Full Text] [Related]
31. Increase in the tight junction protein claudin-1 in intestinal inflammation.
Poritz LS; Harris LR; Kelly AA; Koltun WA
Dig Dis Sci; 2011 Oct; 56(10):2802-9. PubMed ID: 21748286
[TBL] [Abstract][Full Text] [Related]
32. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.
Söderholm JD; Streutker C; Yang PC; Paterson C; Singh PK; McKay DM; Sherman PM; Croitoru K; Perdue MH
Gut; 2004 Dec; 53(12):1817-24. PubMed ID: 15542521
[TBL] [Abstract][Full Text] [Related]
33. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis.
Carlsson AH; Yakymenko O; Olivier I; Håkansson F; Postma E; Keita AV; Söderholm JD
Scand J Gastroenterol; 2013 Oct; 48(10):1136-44. PubMed ID: 23971882
[TBL] [Abstract][Full Text] [Related]
34. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease.
Söderholm JD; Olaison G; Peterson KH; Franzén LE; Lindmark T; Wirén M; Tagesson C; Sjödahl R
Gut; 2002 Mar; 50(3):307-13. PubMed ID: 11839706
[TBL] [Abstract][Full Text] [Related]
35. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1.
Fischer A; Gluth M; Weege F; Pape UF; Wiedenmann B; Baumgart DC; Theuring F
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G218-28. PubMed ID: 24309183
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology of nasal polyposis: the role of desmosomal junctions.
Zuckerman JD; Lee WY; DelGaudio JM; Moore CE; Nava P; Nusrat A; Parkos CA
Am J Rhinol; 2008; 22(6):589-97. PubMed ID: 19178795
[TBL] [Abstract][Full Text] [Related]
38. Herbs-partitioned moxibustion improves intestinal epithelial tight junctions by upregulating A20 expression in a mouse model of Crohn's disease.
Shi Y; Guo Y; Zhou J; Wu L; Chen L; Sun Y; Li T; Zhao J; Bao C; Wu H
Biomed Pharmacother; 2019 Oct; 118():109149. PubMed ID: 31302421
[TBL] [Abstract][Full Text] [Related]
39. Catalytic antibodies in arrhythmogenic cardiomyopathy patients cleave desmoglein 2 and N-cadherin and impair cardiomyocyte cohesion.
Yeruva S; Stangner K; Jungwirth A; Hiermaier M; Shoykhet M; Kugelmann D; Hertl M; Egami S; Ishii N; Koga H; Hashimoto T; Weis M; Beckmann BM; Biller R; Schüttler D; Kääb S; Waschke J
Cell Mol Life Sci; 2023 Jul; 80(8):203. PubMed ID: 37450050
[TBL] [Abstract][Full Text] [Related]
40. Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn's Disease in a Three-dimensional Cell Culture Model.
Xu P; Elamin E; Elizalde M; Bours PPHA; Pierik MJ; Masclee AAM; Jonkers DMAE
Sci Rep; 2019 Feb; 9(1):2030. PubMed ID: 30765731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
